Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness and P&G

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble has signed a "non-binding letter of intent" with Inverness Medical Innovations to "form a joint venture to develop and market consumer diagnostic products," the firms announce July 18. The planning required to reach a final agreement will "take several months," they add. The agreement will combine Inverness' experience developing and manufacturing consumer diagnostics with P&G's knowledge of marketing consumer healthcare products, Waltham, Mass.-based Inverness states. Current consumer diagnostic offerings by Inverness include several pregnancy, ovulation and fertility tests under the Clearblue, FactPlus, Accu-Clear, Persona and Clearplan brands...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS099581

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel